Suzuki Takeki, Agarwal Sunil K, Deo Rajat, Sotoodehnia Nona, Grams Morgan E, Selvin Elizabeth, Calkins Hugh, Rosamond Wayne, Tomaselli Gordon, Coresh Josef, Matsushita Kunihiro
Department of Medicine, University of Mississippi Medical Center, Jackson, MS.
Department of Medicine, Johns Hopkins University School of Medicine, Maryland, MD.
Am Heart J. 2016 Oct;180:46-53. doi: 10.1016/j.ahj.2016.07.004. Epub 2016 Jul 14.
Individuals with chronic kidney disease, particularly those requiring dialysis, are at high risk of sudden cardiac death (SCD). However, comprehensive data for the full spectrum of kidney function and SCD risk in the community are sparse. Furthermore, newly developed equations for estimated glomerular filtration rate (eGFR) and novel filtration markers might add further insight to the role of kidney function in SCD.
We investigated the associations of baseline eGFRs using serum creatinine, cystatin C, or both (eGFRcr, eGFRcys, and eGFRcr-cys); cystatin C itself; and β2-microglobulin (B2M) with SCD (205 cases through 2001) among 13,070 black and white ARIC participants at baseline during 1990-1992 using Cox regression models accounting for potential confounders.
Low eGFR was independently associated with SCD risk: for example, hazard ratio for eGFR <45 versus ≥90mL/(min 1.73m(2)) was 3.71 (95% CI 1.74-7.90) with eGFRcr, 5.40 (2.97-9.83) with eGFRcr-cys, and 5.24 (3.01-9.11) with eGFRcys. When eGFRcr and eGFRcys were included together in a single model, the association was only significant for eGFRcys. When three eGFRs, cystatin C, and B2M were divided into quartiles, B2M demonstrated the strongest association with SCD (hazard ratio for fourth quartile vs first quartile 3.48 (2.03-5.96) vs ≤2.7 for the other kidney markers).
Kidney function was independently and robustly associated with SCD in the community, particularly when cystatin C or B2M was used. These results suggest the potential value of kidney function as a risk factor for SCD and the advantage of novel filtration markers over eGFRcr in this context.
慢性肾脏病患者,尤其是那些需要透析的患者,发生心源性猝死(SCD)的风险很高。然而,关于社区中全谱肾功能与SCD风险的全面数据却很稀少。此外,新开发的估计肾小球滤过率(eGFR)方程和新型滤过标志物可能会进一步深入了解肾功能在SCD中的作用。
我们在1990 - 1992年基线时对13070名参加动脉粥样硬化风险社区研究(ARIC)的黑人和白人参与者进行了研究,使用Cox回归模型并考虑潜在混杂因素,调查了使用血清肌酐、胱抑素C或两者(eGFRcr、eGFRcys和eGFRcr - cys)得出的基线eGFR、胱抑素C本身以及β2 - 微球蛋白(B2M)与SCD(至2001年共205例)之间的关联。
低eGFR与SCD风险独立相关:例如,eGFRcr显示eGFR <45与≥90mL/(min·1.73m²)相比的风险比为3.71(95%CI 1.74 - 7.90),eGFRcr - cys为5.40(2.97 - 9.83),eGFRcys为5.24(3.01 - 9.11)。当eGFRcr和eGFRcys一起纳入单个模型时,仅eGFRcys的关联具有显著性。当将三种eGFR、胱抑素C和B2M分为四分位数时,B2M与SCD的关联最强(第四四分位数与第一四分位数的风险比为3.48(2.03 - 5.96),而其他肾脏标志物≤2.7)。
在社区中肾功能与SCD独立且密切相关,特别是在使用胱抑素C或B2M时。这些结果表明肾功能作为SCD危险因素的潜在价值,以及在此背景下新型滤过标志物相对于eGFRcr的优势。